Sr Director HVE Therapeutic area Lead Specialty Care

Why Patients Need You

As a leading biopharmaceutical company Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives and our priority is to ensure patients have access to these medicines. The Health Technology Assessment (HTA) Value and Evidence team within Global Access & Value (GAV) organization is responsible for ensuring patients have affordable timely access to medicines and vaccines by advancing innovative value and evidence solutions to inform healthcare decisionmaking.

ROLE SUMMARY

The GAV HTA Value & Evidence Therapeutic Area (TA) Lead Specialty Care directly impacts the ability to achieve business objectives on a global scale by driving functional excellence; leading a team of Health Economics and Outcomes Research (HEOR) subject matter experts; developing and implementing HEOR strategy for assets in partnership with the Global Access Strategy and Pricing Leaders. She/he will lead and/or provide strategic partnership guidance and oversight for the development management design implementation and delivery of the value and evidence strategy (VES) and tactical plans for pipeline and marketed assets.

She/he is responsible for ensuring the delivery of foundational and compelling evidence to support product development from early pipeline through lifecycle management within the Specialty therapeutic area through early scientific advice payer and market insights crossfunctional partnerships and external collaborations. She/he will foster the development and maintenance of excellent working relations with external HEOR experts/thought leaders to ensure appropriate methods in health economics RWE and outcomes research and quality of life research are applied in accordance with Pfizer policies.

The HTA Value & Evidence TA Lead is also responsible for fostering actions and behaviors that exemplifies Pfizers values (Courage Excellence Equity and Joy) and prioritizing the development of team members value and evidence competencies talent management and developing strong partnerships with the Global Teams (i.e. Commercial Medical Affairs WRDM GPD) alliance partners and key prioritized markets. The TA leader will function with a OnePfizer mindset and will partner with cross functional teams of Global Access Strategy and Pricing clinical development medical affairs biostatistics global health economics and outcomes research (HEOR) subject matter experts (SMEs) PCOA directors real world evidence (RWE) scientists and others. She/he will join the HV&E leadership team to ensure there is harmonization and alignment on the VES and tactical across all TA and programs. The HTA Value & Evidence Therapeutic Area Lead will be a strategic partner to GAV Centers of Excellence Medical Regulatory Global marketing teams and prioritized country teams. She/he will ensure key stakeholders including TA aligned business leaders are regularly updated on VES and tactical plans.

Role Responsibilities

• Driving Functional Excellence:
  • Drive functional excellence of the Value & Evidence TA team comprised of HV&E indication/assets leads and SMEs to develop and implement HEOR strategy for assets/BU in partnership with HV&E Leader
  • Lead and/or oversight of HV&E resource planning and allocation to support projects based on the needs of the therapeutic area portfolio
  • Drive best practice sharing across the team in support of strategy development and deepening team skills and competencies
  • Optimize the development of processes and SOPs to ensure the highest level of planning and consistency for TPPs GVDs HTA submissions HEOR PCOA and RWE research
  • Foster a team culture that embraces collaboration innovation and scientific excellence with a focus on creating new capabilities to meet the needs of the evolving healthcare landscape data generation and communication collaboration with WRDM GPD Medical Affairs to ensure successful commercialization and access and talent development

• Strategic Partnership:
  • Become an active member of the HTA Value & Evidence leadership team and a strategic partner in aligned therapeutic areas
  • Builds trust and strong relationships with key partners and stakeholders (WRDM Medical Affairs GPD Regulatory and prioritized countries) and other functions across Pfizer

• Plan & Deliver on Commitments:
  • Lead and/or provide oversight for the development management and implementation of the global integrated value and evidence strategy and tactical plans for pipeline and marketed assets within TA.
  • Lead and/or provide oversight of the development of value and evidence communications that differentiate assigned products for payers policymakers providers patients and other stakeholders

• External Partnerships:
  • Develop strategic partnerships and research collaborations with key external experts healthcare policy makers HTAs and payers patient advocacy groups and various academic and community settings to support value and evidence asset strategies
  • Maintain awareness of scientific developments in assigned therapeutic area(s) new and innovative methodologies and trends in the evolving healthcare landscape to assure incorporation into the integrated value and evidence strategies within TA

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers and develop and coach others to achieve meaningful outcomes and create business impact.

• Minimum Masters Degree in a relevant discipline such as but not limited to health services research health outcomes research epidemiology pharmacy administration public health psychology economics statistics or decision sciences plus minimum 10 years of experience in industry or consulting in HTA HEOR and / or market access & pricing fields; 7 years of experience required with Doctoral degree PhD DrPH ScD PharmD
• In depth strategic methodologic and technical understanding of Pharmacoeconomics health economic modeling HTA HealthRelated Quality of Life and / or market access dynamics is required
• Knowledge and experience in early drug development and commercialization is preferred.
• Experienced in leading a cross functional team with strong track record of high level of engagement and delivering results is preferred
• Strong technical and methodological skills (study design data analysis interpretation communication) in clinical trials epidemiology or health services research registries Phase IV studies and observational study design and implementation is preferred
• Experience with US and EU5 payers is required
• Experience with HTA organizations such as ICER NICE SMC PBAC is preferred
• Excellent interpersonal skills and demonstrated track record of accelerating crossfunctional team decisionmaking within a matrix organization through influence is required
• Excellent interpersonal skills is required: ability to understand and respond to multiple internal and external customers; build strategic partnerships internally and externally
• Excellent oral and written English communication skills is required
• Strong project management abilities (contracting budgeting vendor management) is required
• Demonstrated ability to manage multiple projects (multitask) involving complex processes significant budget competing deadlines and rapidly shifting priorities is required

PREFFERED QUALIFICATIONS

• PhD or similar advanced degree in health services research public health epidemiology or health economics or psychometric research and 7 years of experience in pharmaceutical industry HEOR consulting or HEOR academic roles or related experience.
• Experience in Specialty Care from an HEOR perspective.
• Technical and methodological aspects of RWE such as retrospective and prospective observational study design and implementation in US and other countries (real world evidence)
• In depth understanding of Pharmacoeconomics including advanced modelling techniques healthrelated quality of life other PRO measures and macroeconomics.

Primary groups or key role(s) that this role will have interaction with as a regular part of the role responsibilities

External

• Key payers IDNs and HTA bodies Quasi HTA bodies such as ICER.
• Leadership at outcomes research/market access and policy vendors/consulting firms
• Academic/Scientific KOLs & Leadership at key professional organizations such as AUA ASCO ISPOR AMCP

Internal

• HTA Value & Evidence LT
• Global Access Strategy & Pricing (GASP)
• Medical Evidence Generation
• US and Global Medical Affairs
• Field Medical Teams
• GAV Centers of Excellence
• Global Product Development
• PFE Publications teams
• Commercial Development
• Regulatory
• Biostatistics
• Contracting and Operations
• International Policy / Corporate Affairs

Other Job Details:

• Last Date to Apply for Job: April 29th 2025.
• Ability to travel domestically or internationally based on business needs
• NOT eligible for Relocation Package
• Position is hybrid and will require to work 2/3 days a week from site
• Ability to work in all US time zones

The annual base salary for this position ranges from $242000.00 to $403400.00. In addition this position is eligible for participation in Pfizers Global Performance Plan with a bonus target of 25.0 of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of lifes moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution paid vacation holiday and personal days paid caregiver/parental and medical leave and health benefits to include medical prescription drug dental and vision coverage. Learn more at Pfizer Candidate Site U.S. Benefits . Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.

Market Access